3,3-diphenylalanine has been researched along with ubiquinone in 1 studies
| Studies (3,3-diphenylalanine) | Trials (3,3-diphenylalanine) | Recent Studies (post-2010) (3,3-diphenylalanine) | Studies (ubiquinone) | Trials (ubiquinone) | Recent Studies (post-2010) (ubiquinone) |
|---|---|---|---|---|---|
| 5 | 0 | 1 | 9,497 | 597 | 3,655 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daldal, F; Dutton, PL; Gibney, BR; Moser, CC; Palmitessa, A; Sharp, RE; White, JL | 1 |
1 other study(ies) available for 3,3-diphenylalanine and ubiquinone
| Article | Year |
|---|---|
Ubiquinone binding capacity of the Rhodobacter capsulatus cytochrome bc1 complex: effect of diphenylamine, a weak binding QO site inhibitor.
Topics: Binding Sites; Electron Spin Resonance Spectroscopy; Electron Transport Complex III; Enzyme Activation; Enzyme Inhibitors; Iron-Sulfur Proteins; Oxidation-Reduction; Phenylalanine; Rhodobacter capsulatus; Ubiquinone | 1999 |